Economic evaluation of pneumococcal conjugate vaccination in Finland

By Salo Heini   Sintonen Harri   Pekka Nuorti J   Linna Miika   Nohynek Hanna   Verho Jouko   Kilpi Terhi  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 11-12, 2005-11 ,pp. : 821-832

Informa Healthcare

Access to resources Recommend Favorite

Economic impact of 13‐valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 20, Iss. 4, 2014-08 ,pp. : 333-341

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis

By Sinha Anushua   Constenla Dagna   Valencia Juan Esteban   O'Loughlin Rosalyn   Gomez Elizabeth   de la Hoz Fernando   Valenzuela Maria Teresa   de Quadros Ciro A.  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 24, Iss. 5, 2008-11 ,pp. : 304-313

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Introducción de la vacuna conjugada contra Hib en Chile y Uruguay [Introducing Hib conjugate vaccine in Chile and Uruguay]

By Landaverde Mauricio   Di Fabio José Luis   Ruocco Gloria   Leal Irene   de Quadros Ciro  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 5, Iss. 3, 1999-03 ,pp. : 200-206

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Impact of Pneumococcal Vaccination on Morbidity and Mortality of Geriatric Patients: A Case-Controlled Study

By  

Gerontology, Vol. 49, Iss. 4, 2003-06 ,pp. : 246-250

Karger

Access to resources Recommend Favorite